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ABSTRACT
To investigate factors associated with intention to be vaccinated against COVID-19 we conducted a cross- 
sectional survey of 1,500 UK adults, recruited from an existing online research panel. Data were collected 
between 14th and 17th July 2020. We used linear regression analyses to investigate associations between 
intention to be vaccinated for COVID-19 “when a vaccine becomes available to you” and sociodemo-
graphic factors, previous influenza vaccination, general vaccine attitudes and beliefs, attitudes and beliefs 
about COVID-19, and attitudes and beliefs about a COVID-19 vaccination. 64% of participants reported 
being very likely to be vaccinated against COVID-19, 27% were unsure, and 9% reported being very 
unlikely to be vaccinated. Personal and clinical characteristics, previous influenza vaccination, general 
vaccination beliefs, and beliefs and attitudes about COVID-19 and a COVID-19 vaccination explained 76% 
of the variance in vaccination intention. Intention to be vaccinated was associated with more positive 
general COVID-19 vaccination beliefs and attitudes, weaker beliefs that the vaccination would cause side 
effects or be unsafe, greater perceived information sufficiency to make an informed decision about 
COVID-19 vaccination, greater perceived risk of COVID-19 to others (but not risk to oneself), older age, 
and having been vaccinated for influenza last winter (2019/20). Despite uncertainty around the details of 
a COVID-19 vaccination, most participants reported intending to be vaccinated for COVID-19. Actual 
uptake may be lower. Vaccination intention reflects general vaccine beliefs and attitudes. Campaigns and 
messaging about a COVID-19 vaccination could consider emphasizing the risk of COVID-19 to others and 
necessity for everyone to be vaccinated.
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Introduction
The COVID-19 pandemic has had a huge impact across 
societies, with governments worldwide imposing restrictions 
of movement and other measures such as mandatory use of 
face coverings or quarantine to prevent the spread of the 
virus. As of 2nd October 2020, there have been 467,146 con-
firmed cases of COVID-19 and 42,268 confirmed deaths in 
the UK.1 Hopes of returning to normality have been pinned 
on the availability of a COVID-19 vaccine, and vaccination is 
central to the UK government’s COVID-19 recovery 
strategy.2 Vaccine trials have reported encouraging results 
indicating that a COVID-19 vaccine is safe and produces 
a good immune response.3,4 However, the success of 
a vaccination program will depend on rates of uptake 
among the population. It is important to prepare and develop 
effective policies and messaging for vaccination now, in order 
to maximize uptake when a vaccine becomes available.
There is a wealth of literature investigating factors asso-
ciated with vaccine uptake. Research is underpinned by multi-
ple theories of health behavior, including the Health Belief 
Model,5 the Theory of Planned Behavior,6 and Protection 
Motivation Theory.7 Constructs outlined by these theories – 
including threat appraisal, coping appraisal, cues to action, 
self-efficacy, perceived benefits and barriers, subjective 
norms, perceived behavioral control, and attitudes, – have 
consistently been associated with uptake of routine 
vaccination8,9 as well as vaccine uptake during the H1N1 
influenza pandemic.10 In addition to these theoretical con-
structs, contextual factors are also known to influence vaccine 
uptake.8 Perceptions and attitudes are in part driven by these 
contextual factors, such as current events in the news and how 
the vaccine is being portrayed in the media. Since a coronavirus 
vaccine is not yet available, we measured intention to have the 
vaccination rather than uptake. Previous research around the 
seasonal influenza and H1N1 influenza vaccinations has 
demonstrated that vaccine beliefs and attitudes are related to 
vaccine intentions, which in turn were found to be a good 
predictor of uptake of those vaccinations.11,12
To date, there have been two studies to our knowledge 
investigating factors associated with intention to be vaccinated 
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against COVID-19 in the UK in clinically vulnerable 
populations.13,14 One study found that increased intention to 
be vaccinated was associated with thinking that the COVID-19 
outbreak would last for a long time, while decreased intention 
was associated with thinking that the risks of COVID-19 had 
been exaggerated by the media.13 These results should be 
interpreted cautiously as they did not account for the influence 
of participants’ sociodemographic characteristics. The second 
study investigated associations between vaccine intention and 
sociodemographic factors, finding that decreased intention was 
associated with younger age and Black and minority ethnicity, 
but did not investigate the influence of psychological factors on 
vaccination intention.14 Results from these studies should be 
interpreted with caution due to the protracted nature of data 
collection in both studies and the analyses used. However, they 
provide some initial insight into factors associated with 
COVID-19 vaccination intention. It is likely that a COVID- 
19 vaccination will become available first to those in at-risk 
groups and those who have increased exposure to the virus 
through their job.15 However, vaccination intention in the 
general population should be investigated, as vaccination may 
be rolled out more widely soon afterward, and sufficient uptake 
will be critical to eliminating COVID-19. Furthermore, it 
remains a possibility that people who are not in at-risk groups 
and do not have increased exposure to the virus through their 
job may be able to be vaccinated for COVID-19 privately, 
much like the seasonal influenza vaccine, so understanding 
intentions across the whole population is important.
The aim of this study was to investigate associations 
between vaccination intention and theoretically grounded, 
contextual and sociodemographic factors in 
a demographically representative sample of the UK adult 
population.
Method
Design
We conducted a cross-sectional survey, between 14th and 17th 
July 2020. Participants completed the survey online, on 
Qualtrics.
Sample
Participants (n = 1,500) were recruited through Prolific’s 
online research panel and were eligible for the study if they 
were aged 18 years or over and lived in the UK (n = 38,000 
+ eligible participants). Quota sampling was used, based on 
age, sex, and ethnicity, to ensure that the sample was broadly 
representative of the UK general population. Of 1,532 people 
who began the survey, 1,504 completed it (98% completion 
rate). Four participants were not included in the sample as they 
did not meet quality control checks. Participants were paid £2 
for a completed survey.
Measures
Full survey materials are available online.16 Items were based 
on previous literature.17–21
Personal and clinical characteristics
We asked participants to report their age, gender, ethnicity, 
religion, employment status, highest educational or profes-
sional qualification, and total household income. We also 
asked participants what UK region they lived in, how many 
people lived in their household, whether they or someone else 
in their household (if applicable) had a chronic illness that 
made them clinically vulnerable to serious illness from 
COVID-19, and if they worked or volunteered in roles con-
sidered critical to the COVID-19 response (‘key worker’ roles).
Lastly, we asked participants if they had been vaccinated for 
seasonal influenza last winter (yes/no), and how likely they would 
be to have the seasonal influenza vaccine this winter (eleven 
point scale, from “extremely unlikely” to “extremely likely”).
Psychological factors
We asked participants to what extent they thought “corona-
virus poses a risk to” people in the UK and to themselves 
personally, on a five-point scale, from “no risk at all” to 
“major risk.”
We asked participants if they thought they “have had, or 
currently have, coronavirus.” Participants could answer “I have 
definitely had it or definitely have it now,” “I have probably had 
it or probably have it now,” “I have probably not had it and 
probably don’t have it now,” and “I have definitely not had it 
and definitely don’t have it now.” We also asked participants if 
they personally knew anyone who had COVID-19 (yes/no).
Participants were asked a series of statements about 
COVID-19 (n = 8) and about a possible COVID-19 vaccina-
tion (n = 24). For questions about the COVID-19 vaccination, 
participants were asked to imagine that a COVID-19 vaccine 
was widely available. Statements measured theoretical con-
structs including perceived susceptibility to COVID-19, sever-
ity of COVID-19, benefits of a COVID-19 vaccine, barriers to 
being vaccinated against COVID-19, ability to be vaccinated 
(self-efficacy), subjective norms, behavioral control, antici-
pated regret, knowledge, trust in the Government and in the 
NHS. These items also investigated concerns about commercial 
profiteering, and participants’ beliefs about vaccination allow-
ing life to get back to ‘normal’ and having to follow social 
distancing and other restrictions for COVID-19 if vaccinated. 
Participants rated perception statements on an eleven-point 
scale (0–10) from “strongly disagree” to “strongly agree.” We 
also asked participants if their employer would want them to 
have the COVID-19 vaccination. Order of items was quasi- 
randomized.
Outcome measure
To measure vaccination intention, we asked participants to 
state how likely they would be to have a COVID-19 vaccination 
“when a coronavirus vaccination becomes available to [them]” 
on an eleven-point scale from “extremely unlikely” (0) to 
“extremely likely” (10).
Ethics
Ethical approval for this study was granted by Keele 
University’s Research Ethics Committee (reference: PS- 
200129).
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Patient and public involvement
Due to the rapid nature of this research, the public was not 
involved in the development of the survey materials.
Sample size
A target sample size of 1500 was chosen to provide a high ratio 
of cases to estimated parameters in order to avoid overfitting 
and loss of generalizability in the regression model.22
Analysis
To identify variables associated with an intention to have the 
COVID-19 vaccination, we constructed a linear regression 
model. Ordinal and multinomial predictors were converted 
to dummy variables. To aid interpretation of the model, and 
to address collinearity in some variables, we ran principal 
component analyses on items investigating beliefs and atti-
tudes about COVID-19 and a COVID-19 vaccination.
Variables entered into the model were selected a priori 
based on their theoretical relevance; no variable selection pro-
cedures were employed. Five groups of variables were included 
in the model: personal and clinical characteristics; seasonal 
influenza vaccination; general beliefs and attitudes relating to 
vaccination; beliefs and attitudes relating to COVID-19 illness; 
and beliefs and attitudes relating to COVID-19 vaccination. 
The percentage of variance in the outcome variable explained 
by each predictor was calculated as the squared semi-partial 
correlation for a numerical predictor and the change in R2 
attributable to a set of dummy variables.
As well as fitting the full model, we also added the groups of 
variables as successive blocks in a hierarchical model, to deter-
mine the incremental increase in the adjusted R2 value as the 
groups of variables were added to the model.
Due to the large number of predictors in the model, statis-
tical significance was set at p ≤ .01 to control Type 1 errors and 
99% confidence intervals (CIs) were correspondingly calcu-
lated for the regression coefficients. Assumptions of the analy-
sis were checked. Analyses were conducted in SPSS 26.
Results
As intended, participants were broadly representative of the 
UK population (mean age 46.0 years, SD = 15.8, range 18 to 87; 
51% female; 85% white ethnicity; Table 1, see supplementary 
materials 1 for further breakdown).
Descriptive statistics for items assessing psychological fac-
tors are reported in Tables 2 and 3. Participants perceived 
a greater risk of COVID-19 to others (73.4% reporting 
a significant or major risk of COVID-19 to people in the UK) 
than to themselves personally (35.6% significant or major risk). 
Endorsement of the item “we are all responsible for reducing 
the spread of coronavirus” was also high. Participants reported 
greater likelihood of having a coronavirus vaccination than 
a seasonal influenza vaccination. It is also noteworthy that 
participants reported considerably more trust in the NHS 
compared to the Government regarding managing the 
pandemic.
Principal component analyses
Two components emerged from the principal component ana-
lysis on beliefs and attitudes about COVID-19 (see supplemen-
tary materials 2). The first component reflected items about 
perceived severity of COVID-19, perceived immunity to the 
virus, and impact of the pandemic on one’s life (“perceived 
threat and impact of COVID-19”). The second component 
measured trust in the NHS and the Government to manage 
the COVID-19 pandemic in the UK (“trust in COVID-19 
management”).
When investigating items related to a COVID-19 vaccina-
tion, four components emerged from this principal compo-
nent analysis (see supplementary materials 2). The first 
component measured “general COVID-19 vaccination beliefs 
and attitudes,” with items loading onto this factor investigat-
ing perceived vaccine effectiveness, social norms, likelihood of 
catching COVID-19 without a vaccine, beliefs about manda-
tory vaccination, the influence of vaccine recommendations 
from different sources, anticipated regret of not being vacci-
nated, and perceived ease of vaccination. The second compo-
nent, termed “COVID-19 vaccination adverse effects” 
measured perception of adverse effects and novelty of the 
vaccine. The third component measured perceived informa-
tion sufficiency to be able to make an informed decision 
about vaccination (“perceived knowledge sufficiency”). Items 
about vaccination allowing a return to ‘normal’ life and not 
having to follow social distancing and other restrictions if one 
were vaccinated loaded on to the fourth component (“return 
to ‘normal’ life”).
Vaccination intention
Participants’ vaccination intention is presented in Figure 1. 
Vaccination intention exhibited a marked negative skew 
(mean = 7.55, standard deviation = 2.92, median = 9). In 
order to categorize respondents in terms of their vaccination 
intention, we applied a priori cutpoints to the 0–10 scale (with 
scores of zero to two as “very unlikely,” three to seven as 
“uncertain” and eight to ten as “very likely”), 9.1% (95% CI 
7.8%, 10.7%) reported being very unlikely to be vaccinated 
(n = 137), 26.9% (95% CI 24.7%, 29.2%) reported being uncer-
tain about their likelihood of vaccination (n = 403), and 64.0% 
(95% CI 61.5%, 66.4%) reported being very likely to be vacci-
nated (n = 960).
The final model explained 76% of the variance in intention 
to vaccinate (Table 4). Increased likelihood of being vaccinated 
for COVID-19 was significantly associated with older age, 
having been vaccinated for influenza last winter, perceiving 
a greater risk of COVID-19 to people in the UK, more positive 
general COVID-19 vaccination beliefs and attitudes, weaker 
beliefs that the vaccination would cause side effects or be 
unsafe, greater perceived information sufficiency to make an 
informed decision about COVID-19 vaccination, and lower 
endorsement of the notion that only people who are at risk of 
serious illness should be vaccinated for COVID-19. In terms of 
explained variance, the strongest predictors were the principal 
components representing general COVID-19 vaccination 
beliefs and attitudes (19.5% of variance explained), followed 
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by vaccination adverse effects and novelty (8.2% of variance 
explained).
When the groups of variables were entered hierarchically as 
blocks, we can infer the percentage of additional variance 
explained by each block from the change in incremental 
adjusted R2. Addition of each subsequent block explained 
a statistically significant proportion of the variance (p < .001 
in each case). Personal and clinical characteristics (block 1) 
alone explained very little (4%) of the variance in intention to 
be vaccinated. When previous influenza vaccination (block 2) 
was added, it explained an additional 7% of the variance. 
Adding general vaccination beliefs and attitudes (block 3) 
resulted in the largest increase in proportion (34%) of 
explained variance (though in the full model the predictors in 
this group were no longer significant). When beliefs and atti-
tudes about COVID-19 (block 4) were added to the model, 
they explained 4% more of the variance in vaccination inten-
tion. Adding positive beliefs and attitudes about a COVID-19 
vaccination (block 5) explained a further 28% of the variance.
Discussion
If COVID-19 vaccination were to be offered to the general 
population, one advantage might be the ability to achieve 
herd immunity. Information about herd immunity and vacci-
nation estimates are rapidly changing. While some estimates 
indicate that up to 60% of the population might need to be 
vaccinated to achieve this,23 recent research suggests this per-
centage could be considerably lower depending on variation in 
population characteristics such as susceptibility and 
exposure.24,25 Sixty-four percent of people surveyed reported 
intending to be vaccinated for COVID-19 when a vaccine 
becomes available to them. While intention is a key driver of 
the uptake of health behaviors,6,7 vaccination intention is likely 
to be greater than actual vaccine uptake.26 Therefore, it is 
important to identify factors associated with vaccination inten-
tion early on, to support policy and communications when 
a vaccine becomes available. We found that, taken together, 
personal and clinical characteristics, previous influenza vacci-
nation, general vaccination beliefs, and beliefs and attitudes 
Table 1. Participant characteristics.
Personal and clinical characteristics Level n (%)
Sex Male 729 
(48.6)
Female 765 
(51.0)
Other 6 (0.4)
Ethnicity White 1267 
(84.5)
Black and minority 
ethnic
224 
(14.9)
Prefer not to say 9 (0.6)
Religion No religion 780 
(52.0)
Christian 592 
(39.5)
Other religion 116 (7.7)
Prefer not to say 12 (0.8)
Highest qualification Degree equivalent or 
higher+
789 
(52.6)
Other or no 
qualifications
704 
(46.9)
Prefer not to say 7 (0.5)
Employment status Full-time 678 
(45.2)
Part-time 257 
(17.1)
Not working/other 556 
(37.1)
Don’t know 1 (0.1)
Prefer not to say 8 (0.5)
Key worker Yes 549 
(36.6)
No 951 
(63.4)
Total household income* Under £10,000 103 (6.9)
£10,000–£19,999 207 
(13.8)
£20,000–£29,999 309 
(20.6)
£30,000–£39,999† 258 
(17.2)
£40,000–£49,999 191 
(12.7)
£50,000–£74,999 210 
(14.0)
£75,000 or over 136 (9.1)
Don’t know 20 (1.3)
Prefer not to say 66 (4.4)
Region where respondent lives* East Midlands 111 (7.4)
East of England 109 (7.3)
London 224 
(14.9)
North East 65 (4.3)
North West 143 (9.5)
Northern Ireland 30 (2.0)
Scotland 130 (8.7)
South East 215 
(14.3)
South West 148 (9.9)
Wales 66 (4.4)
West Midlands 127 (8.5)
Yorkshire and the 
Humber
131 (8.7)
Prefer not to say 1 (1)
Number of people in household* 1 235 
(15.7)
2† 572 
(38.1)
3–4 553 
(36.9)
5–6 126 (8.4)
7 or more 11 (7.0)
Prefer not to say 3 (0.2)
Extremely clinically vulnerable – 
respondent
Yes 445 
(29.7)
(Continued)
Table 1. (Continued).
Personal and clinical characteristics Level n (%)
No 1055 
(70.3)
Extremely clinically vulnerable – other(s) in 
household
Yes 455 
(36.0)
No 810 
(64.0)
Not applicable 235
Influenza vaccination last winter Yes 485 
(32.3)
No 1001 
(66.7)
Don’t know 14 (0.9)
* Not included in regression model 
† Median category 
+ Undergraduate (e.g. BA, BSc) or postgraduate (e.g. MA, MSc, PhD) degree or 
other technical, professional or higher qualification.
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Table 2. Descriptive statistics for continuous items measuring beliefs and attitudes about COVID-19 and a COVID-19 vaccination and vaccination intention. Data are mean 
(standard deviation) on a 0–10 numerical rating scale (0 = strongly disagree, 10 = strongly agree).
Item
Mean 
(SD)
Attitudes and beliefs about COVID-19 I am worried about catching coronavirus 6.24 
(2.71)
I believe that coronavirus would be a mild illness for me 4.35 
(2.63)
Too much fuss is being made about the risk of coronavirus* 2.10 
(2.54)
We are all responsible for reducing the spread of coronavirus* 9.23 
(1.40)
I believe I am immune to coronavirus* 1.16 
(1.96)
The coronavirus pandemic has had a big impact on my life 6.81 
(2.43)
I trust the NHS to manage the coronavirus pandemic in the UK 7.28 
(2.16)
I trust the Government to manage the coronavirus pandemic in the UK 3.96 
(2.91)
Attitudes and beliefs about a COVID-19 
vaccination
A coronavirus vaccination should be mandatory for everyone who is able to have it 6.51 
(3.41)
Without a coronavirus vaccination, I am likely to catch coronavirus 5.57 
(2.39)
If I get a coronavirus vaccination, I will be protected against coronavirus 6.83 
(2.35)
If I don’t get a coronavirus vaccination and end up getting coronavirus, I would regret not getting the 
vaccination*
7.83 
(2.94)
It would be very easy for me to have a coronavirus vaccination* 7.24 
(2.63)
A coronavirus vaccination could give me coronavirus 2.84 
(2.67)
I would be worried about experiencing side effects from a coronavirus vaccination 5.63 
(3.02)
I might regret getting a coronavirus vaccination if I later experienced side effects from the vaccination 5.55 
(2.92)
A coronavirus vaccination will be too new for me to be confident about getting vaccinated 4.83 
(3.17)
Most people will get a coronavirus vaccination 6.73 
(1.98)
Other people like me will get a coronavirus vaccination* 7.43 
(2.21)
In general, vaccination is a good thing* 8.69 
(2.05)
I am afraid of needles* 2.75 
(3.35)
If I were vaccinated, I think I would not need to follow social distancing and other restrictions for coronavirus 3.93 
(2.91)
I know enough about the coronavirus illness to make an informed decision about whether or not to get 
vaccinated
6.74 
(2.61)
I know enough about the coronavirus vaccine to make an informed decision about whether or not to get 
vaccinated
4.00 
(2.98)
Only people who are at risk of serious illness from coronavirus need to be vaccinated 3.02 
(3.02)
My family would approve of my having a coronavirus vaccination* 8.01 
(2.38)
My friends would approve of my having a coronavirus vaccination* 7.80 
(2.28)
If a coronavirus vaccination were recommended by the Government, I would get vaccinated 6.85 
(2.92)
If a coronavirus vaccination were recommended by a health care professional, I would get vaccinated* 7.90 
(2.62)
Widespread coronavirus vaccination is just a way to make money for vaccine manufacturers* 2.73 
(2.81)
A coronavirus vaccine will allow us to get back to ‘normal’ 6.66 
(2.52)
There would be no point in having the coronavirus vaccination unless I could go back to my normal life 3.86 
(3.04)
Vaccination intentions This winter, how likely is it you will have the seasonal influenza vaccination? (0 = very unlikely, 10 = very likely) 5.11 
(4.02)
When a coronavirus vaccination becomes available to you, how likely is it you will have one? (0 = very unlikely, 
10 = very likely)*
7.55 
(2.92)
* Skewed variables; mean values should be interpreted cautiously.
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about COVID-19 and a COVID-19 vaccination explained 76% 
of the variance in vaccination intention.
Importantly, we found that the factor that explained the 
greatest proportion of the variance in vaccination intention 
(20%) was COVID-19 vaccination beliefs and attitudes. This 
factor encompassed items measuring positive influence of 
recommendations from authorities to be vaccinated, greater 
perceived social norms about vaccination, greater perceived 
effectiveness, greater perceived likelihood of catching 
COVID-19 without a vaccine, greater anticipated regret of 
not being vaccinated, beliefs that COVID-19 vaccination 
should be mandatory and greater perceived ease of vaccina-
tion. These map on to theoretical constructs of threat apprai-
sal, coping appraisal, subjective norms, and self-efficacy 
outlined by theories of uptake of health behaviors,5–7 which 
were also associated with uptake of vaccination during the 
H1N1 influenza pandemic.10 Earlier research investigating 
COVID-19 vaccine willingness in the UK found no associa-
tion with perceived likelihood of catching COVID-19, trust in 
authorities, or clarity of information about the virus.13 
However, those earlier results should be interpreted with 
caution as analyses did not control for personal or clinical 
characteristics and data were collected early in the pandemic. 
Our results suggest that people may hold general positive or 
negative beliefs and attitudes toward the vaccination and this 
general sense is driving vaccination intention at this point. 
While a COVID-19 vaccination has so far generally been 
positively framed in the media, as more information – and 
misinformation – about the vaccine comes to light, there is 
the potential for this general positive sentiment to be eroded, 
negatively influencing vaccination intention and uptake. 
Since our survey was conducted, the UK trial of 
a coronavirus vaccine by the University of Oxford and 
AstraZeneca was halted for a week in September 2020 
following the adverse reaction of a patient.27 It is unclear 
what impact, if any, this might have on vaccination intentions 
and how long any impact might last. Regular and longitudinal 
assessments such as the one we report here can help clarify 
such impacts.
Details around COVID-19 vaccination remain uncertain 
until a vaccine has been developed, but will become clearer as 
more information is available regarding vaccine composition 
(immunogenicity and safety), and immunity after having con-
tracted COVID-19.15 We found that vaccination intention was 
associated with greater perceived information sufficiency about 
COVID-19 and a COVID-19 vaccination. In the case of 
COVID-19, a perception of sufficient information about the 
vaccination is interesting as there is currently little such infor-
mation available. What information there is comes from results 
of vaccine trials that were still underway at the time of data 
collection. These results may therefore reflect participants’ 
general vaccine beliefs and attitudes.
In contrast to previous research,10 we found no evidence of 
an association between greater perceived risk of COVID-19 to 
oneself and vaccination intention. However, greater perceived 
risk to others was associated with vaccination intention in our 
study. This suggests that vaccination campaigns and messaging 
highlighting the need for vaccination for altruistic reasons (i.e. 
to protect others) might be particularly effective. We also found 
that concerns about adverse effects and vaccine novelty were 
associated with vaccination intention. As novel threats are 
perceived as inherently more risky,28 and perceiving adverse 
effects is consistently associated with vaccination refusal,9,10 
this is unsurprising.
Eligibility criteria for a COVID-19 vaccination are not yet 
clear. Initial guidance from the Joint Committee on 
Vaccination and Immunization suggests that vaccination 
should be prioritized among frontline health and social care 
Table 3. Descriptive statistics for categorical and ordinal items measuring beliefs and attitudes about COVID-19 and a COVID-19 vaccination.
Item Level n (%)
To what extent do you think coronavirus poses a risk to people in the UK? No risk at all 5 (0.3)
Minor risk 80 (5.3)
Moderate risk 313 (20.9)
Significant risk 675 (45.0)
Major risk 426 (28.4)
Don’t know 1 (0.1)
To what extent do you think coronavirus poses a risk to you personally? No risk at all 34 (2.3)
Minor risk 365 (24.3)
Moderate risk 563 (37.5)
Significant risk 381 (25.4)
Major risk 153 (10.2)
Don’t know 4 (0.3)
Do you believe you have had, or currently have, coronavirus? Definitely not 555 (37.0)
Probably not 588 (39.2)
Probably 151 (10.1)
Definitely 28 (1.9)
Don’t know 178 (11.9)
Do you personally know anyone (excluding yourself) who has had coronavirus? Yes 677 (45.2)
Don’t know 822 (54.8)
Prefer not to say 1 (0.1)
As far as you know, would your employer want you to have the coronavirus vaccination? Yes 597 (61.2)
No 18 (1.8)
Don’t know 361 (37.0)
Not applicable 524
As far as you know, is there currently a widely available vaccination to protect against coronavirus? Yes 53 (3.5)
No 1360 (90.7)
Don’t know 82 (5.5)
Prefer not to say 5 (0.3)
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workers and those at increased risk of critical illness or death 
from COVID-19.15 We found no evidence of an association 
between clinical vulnerability to COVID-19 and vaccination 
intention. However, vaccination intention was lower in those 
who thought that only those who are at risk of serious illness 
need to be vaccinated. This may be because most of the sample 
did not think that they were at increased clinical risk of 
COVID-19. Our finding that thinking that one has had 
COVID-19 was not associated with vaccination intention is 
reassuring.
With some evidence suggesting that repeated vaccination 
for COVID-19 may be necessary,23 parallels with seasonal 
influenza vaccination can be drawn and lessons learned to 
promote vaccination uptake. Populations at greater clinical 
risk of serious illness from COVID-19 are also similar to 
those at risk of serious illness from influenza, and target 
populations for vaccines are likely to be similar. We found 
that seasonal influenza vaccination was strongly associated 
with COVID-19 vaccination intention. Taken together, these 
factors may suggest that in future years, co-administration of 
the seasonal influenza and COVID-19 vaccines could be con-
sidered. In the meantime, with the 2020/21 influenza season 
fast approaching in the UK at the time of writing, and an 
increasing strain that concurrent circulation of seasonal influ-
enza and COVID-19 will put on healthcare services,29 it is 
crucial that uptake of the seasonal influenza vaccine increases 
compared to uptake in 2019/20 (England: 72% in 65+ year 
olds, 45% in a clinical risk category; 44% in pregnant women; 
and 44% in pre-school children and 60% in school-aged 
children30).
Given the prominence of COVID-19 in the media, contextual 
factors are likely to be strongly influential in vaccination uptake,8 
with vaccine sentiments likely reflecting the media discourse. 
However, there was no evidence for an association between 
beliefs about a return to ‘normal’ and COVID-19 vaccination 
intention using our stringent criteria for statistical significance 
(p ≤ .01). This may be due to the continuing uncertainties 
surrounding a COVID-19 vaccination. Given the potential for 
sensationalized stories to increase perceptions of the likelihood 
and severity of adverse effects, decrease vaccine uptake, and in 
some cases lead to political responses including the suspension 
of vaccination programs,31 it is important that when more 
information about a vaccine becomes available, a clear factual 
account is portrayed in the media. It remains to be seen how this 
might be implemented in practice.
In line with other research conducted on COVID-19 vac-
cine willingness in the UK,14 we found that older age was 
associated with greater intention to be vaccinated. This finding 
may reflect the related increased uptake of seasonal influenza 
vaccination in older age groups. It may also reflect the well- 
publicized increased risk of COVID-19-associated morbidity 
and mortality.32
Figure 1. Perceived likelihood of having a vaccination (0 = “extremely unlikely” to 10 = “extremely likely”). The figure also shows cutpoints that we used to categorize 
respondents in terms of their vaccination intention (into three categories of very unlikely, uncertain, and very likely to be vaccinated).
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This study has limitations. First, although we used 
a demographically representative sample of the UK popula-
tion, we cannot be sure how representative survey respon-
dents are of the views and behaviors of the general 
population.33,34 However, we assume that the associations 
between variables follow the same pattern as those in the 
general population.35 Second, we cannot infer causality due 
to the cross-sectional nature of the study. Third, we inves-
tigated vaccination intention. Actual vaccination uptake is 
likely to be lower.26 Given the theoretical importance of 
intention in theories of uptake of health behaviors,6,7 it is 
likely that factors associated with vaccination intention in 
this study will also influence vaccination uptake. Fourth, 
due to unclear evidence of the role of children in transmis-
sion of COVID-19 in the UK15 and space constraints in the 
survey, we chose not to investigate intention to vaccinate 
one’s child for COVID-19. Future research could usefully 
consider the impact of any details that emerge about 
a COVID-19 vaccine, such as how effective the vaccine is 
and how long immunity conferred by the vaccine lasts. It 
would also be useful to conduct age-stratified research to 
further understand how beliefs such as personal risk per-
ception might vary and interact with intention to get vac-
cinated by age.
Table 4. Results of the full linear regression model analyzing associations with vaccination intention (adjusted R2 =.763). Parameter estimates relate to the full model 
containing all predictors. The unstandardized regression coefficients represent the change in likelihood of vaccination for a one-unit increase in the predictor variable 
(or, for dummy variables, a shift from the reference category to the category concerned). The figures under ‘% variance explained’ represent the percentage of variance 
in the outcome variable uniquely explained by the item (or set of dummy variables) concerned. The model was based on 1437 cases with complete data.
Predictor variable Level
Standardized 
coefficient
Unstandardized 
coefficient
99% confi-
dence interval p value
% variance 
explained
Block 1 – personal and clinical characteristics
Age Years .043 .008 .000,.015 .006* 0.12
Sex (reference: female) Male –.012 –.072 –.277,.133 .366 0.01
Ethnicity (reference: black and minority ethnic) White –.008 –.066 –.394,.261 .602 0.01
Religion (reference: none) .580 0.02
Christian –.006 –.033 –.249,.182
Other –.016 –.172 –.604,.259
Qualifications (reference: other) Degree 
equivalent or 
higher
–.004 –.024 –.227,.179 .763 <0.01
Employment status (reference: not working/other) .333 0.04
Part-time .022 .168 –.127,.463
Full-time .008 .047 –.199,.293
Key worker (reference: not key worker) Key worker .015 .093 –.132,.317 .286 0.02
Extremely clinically vulnerable – self (reference: no) Yes –.013 –.079 –.316,.157 .388 0.01
Extremely clinically vulnerable – household member (reference: no) Yes .017 .109 –.107,.324 .195 0.035
Block 2 – previous influenza vaccination
Did you have a vaccination for influenza last winter? (reference: no) Yes .051 .314 .079,.548 .001* 0.19
Block 3 – general vaccination beliefs and attitudes
Vaccination is generally good (0–10) 0–10 scale .014 .020 –.055,.096 .483 0.01
I am afraid of needles (0–10) 0–10 scale –.011 –.010 –.040,.020 .399 0.01
Block 4 – beliefs and attitudes about COVID-19
Perceived risk of COVID-19 to people in the UK (reference: major) .001* 0.26
No or minor risk –.056 –.701 –1.270, –.132
Moderate risk –.049 –.350 –.700,.000
Significant risk –.006 –.033 –.297,.232
Perceived risk of COVID-19 to oneself (reference: major) .501 0.04
No or minor risk .022 .144 –.353,.640
Moderate risk .029 .173 –.239,.585
Significant risk .033 .218 –.162,.597
Do you have/have you had COVID-19? (reference: probably/definitely) .627 0.03
Probably not .009 .056 –.271,.382
Definitely not .015 .089 –.244,.423
Don’t know .022 .192 –.209,.593
Do you know anybody who has had COVID-19? (reference: no) Yes .004 .024 –.178,.225 .762 <0.01
Perceived threat and impact of COVID-19 –.001 –.003 –.155,.149 .960 <0.01
Trust in coronavirus management –.002 –.005 –.115,.106 .913 <0.01
Block 5 – beliefs and attitudes about a COVID-19 vaccination
General COVID-19 vaccination beliefs and attitudes .733 2.144 1.984, 2.304 <.001* 19.71
COVID-19 vaccination adverse effects –.355 –1.030 –1.150, –.911 <.001* 8.18
Perceived knowledge sufficiency .081 .234 .133,.334 <.001* 0.59
Return to ‘normal’ life –.030 –.088 –.193,.017 .031 0.08
Only people who are at risk of serious illness from coronavirus need to 
be vaccinated
0–10 scale –.040 –.038 –.075, –.001 .008* 0.12
Widespread coronavirus vaccination is just a way to make money for 
vaccine manufacturers
0–10 scale .024 .025 –.022,.072 .171 0.03
As far as you know, is there currently a widely-available vaccination to 
protect against coronavirus? (reference: no)
.672 0.01
Yes .011 .179 –.347,.705
Don’t know .003 .038 –.416,.492
* p ≤.01
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High levels of uptake of a COVID-19 vaccination when one 
becomes available will be necessary in order for the UK gov-
ernment’s COVID-19 recovery strategy to be fulfilled. To the 
best of our knowledge, this is the first methodologically rigor-
ous study investigating the intention to receive a COVID-19 
vaccination in a demographically representative sample of the 
UK population. While there is still much uncertainty sur-
rounding COVID-19 and vaccination, results from this study 
provide useful insights that can help guide policy and commu-
nications when a vaccine becomes available. The UK popula-
tion is still divided in their intention to be vaccinated for 
COVID-19. Approximately two-thirds report being likely to 
be vaccinated when a vaccine becomes available to them 
despite the dearth of information about a COVID-19 vaccina-
tion. As vaccine uptake is likely to be lower than vaccination 
intention, it is worrying that the remaining third were unsure 
or did not intend to be vaccinated for COVID-19, given the 
impact of COVID-19 on day-to-day life and prominence of the 
virus in the media. These findings are likely to reflect general 
vaccine attitudes and beliefs and clear information about the 
safety and effectiveness of the vaccine may be needed to 
increase vaccination intentions. Our results indicate that vac-
cination campaigns and communications should draw on the-
oretical constructs. Contextual factors, such as the media 
discourse around a COVID-19 vaccination, are likely to influ-
ence beliefs and attitudes toward the vaccine. Communications 
should also explain and highlight how vaccination can stop the 
spread of COVID-19 to others and facilitate a return to 
normality.
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